Ronald Blue Trust, Inc. Veracyte, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.7 Billion
- Q4 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 12 shares of VCYT stock, worth $417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 2,131
99.44%
Holding current value
$417
Previous $84,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VCYT
# of Institutions
338Shares Held
80.4MCall Options Held
212KPut Options Held
18.5K-
Vanguard Group Inc Valley Forge, PA8.21MShares$285 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$271 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$229 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$146 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$142 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.49B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...